MENU

BICX Stock BioCorRx (BICX, $0.29) was a top loser this quarter, falling -20.06%

A.I.dvisor
at Tickeron.com
Loading...
BICX - BioCorRx Inc.
Tickeron

Loading...

Price: $0.2878
Daily change: -$0.16428 (-36.34%)
Daily volume: 520
3-month price change: -$0.0722 (-20.06%)
Capitalization: $5.4M
Industry: Hospital/Nursing Management
BioCorRx (BICX, $0.29) was a top loser over the last three months, falling -2 to $0.29 per share. A.I.dvisor analyzed 90 stocks in the Hospital/Nursing Management Industry for the 3-month period ending September 5, 2025, and found that of them () exhibited an Uptrend while of them () demonstrated a Downtrend.

BICX's Stochastic Oscillator stays in overbought zone for 1 day

Expect a price pull-back in the near future.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 05, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BICX as a result. In of 125 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

BICX moved below its 50-day moving average on September 05, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BICX crossed bearishly below the 50-day moving average on August 26, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The Aroon Indicator for BICX entered a downward trend on September 05, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BICX's RSI Indicator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BICX just turned positive on September 03, 2025. Looking at past instances where BICX's MACD turned positive, the stock continued to rise in of 61 cases over the following month. The odds of a continued upward trend are .

The 50-day moving average for BICX moved above the 200-day moving average on August 04, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

BICX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (8.660). P/E Ratio (0.000) is within average values for comparable stocks, (116.721). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.012). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. BICX's P/S Ratio (12.804) is very high in comparison to the industry average of (1.547).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BICX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BICX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

View a ticker or compare two or three
BICX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry HospitalNursingManagement

Profile
Fundamentals
Details
Industry
N/A
Address
2390 East Orangewood Avenue
Phone
+1 714 462-4880
Employees
11
Web
https://www.biocorrx.com